{
  "id": "strategic-growth-roadmap",
  "title": "Strategic Growth Roadmap",
  "category": "executive_prompts",
  "author": "Frederick de Ruiter",
  "created": "2025-07-18",
  "last_modified": "2025-07-18",
  "tested_model": "gpt-4o",
  "temperature": 0.2,
  "tags": [
    "executive",
    "growth"
  ],
  "prompt": {
    "purpose": "Rank therapeutic areas for expansion over the next three years.",
    "context": "You are a senior life-sciences market-intelligence analyst. Current service strengths include early-phase oncology, global Phase II\u2013III execution, and decentralized-trial capabilities. Target geographies are APAC (Japan, South Korea) and LATAM (Brazil, Mexico). Constraints include maintaining EBITDA margin \u226518% and a capex budget of $25M.",
    "instructions": "- Assess macro R&D investment trends, trial volume growth, and competitive white space by therapeutic area.\n- Weight each area by expected market CAGR to 2028, outsourcing propensity, and alignment with our capabilities.\n- Draft a prioritized table ranking the top five areas with opportunity score, rationale (\u226460 words), and estimated incremental revenue using the format:\n\n  | Rank | Therapeutic area | Opportunity score (1-100) | 3-line rationale | 2025-2028 revenue ($M) |\n  | --- | --- | --- | --- | --- |\n\n- Conclude with two \u201cno-go\u201d areas and why.\n- Cite 3\u20135 recent industry sources (title, publisher, date) in APA style.",
    "inputs": "- `{{industry_reports}}` \u2013 optional references or market data.",
    "output_format": "Markdown table and a brief notes section.",
    "additional_notes": "Use an executive tone and keep the response concise.",
    "example_usage": "",
    "references": ""
  }
}